Jasper Therapeutics, Inc. · NASDAQ:JSPR
Kingdon Capital Management, L.L.C.'s stake in Jasper Therapeutics, Inc. fell to 4.70% (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 12, 2025
Kingdon Capital Management, L.L.C.'s stake in Jasper Therapeutics, Inc. fell to 4.70%, 1,324,845 shares, as a passive investor on Sep 30, 2025. Filed Nov 12, 2025 (Schedule 13G/A).
- Stake
- 4.70%
- Shares
- 1,324,845
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Kingdon Capital Management, L.L.C. | 4.70% | 1,324,845 |
| Mark Kingdon | 4.70% | 1,324,845 |
Source
Related
- Jasper Therapeutics, Inc.
- Kingdon Capital Management, L.L.C.
- Jasper Therapeutics, Inc. shareholders
- Schedule 13G · Kingdon Capital Management, L.L.C. · Jul 11, 2025
- Schedule 13G · Velan Capital Investment Management LP · Aug 17, 2026
- Schedule 13D/A · Velan Capital Investment Management LP · Jul 20, 2026
- Schedule 13G/A · Millennium Management LLC · Jul 10, 2026
- Schedule 13G/A · Morgan Stanley · May 12, 2026
- Schedule 13G/A · Goldman Sachs Group Inc · May 8, 2026